| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2435277A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | CA2434601A1 Methods for specifically inhibiting histone deacetylase-4 |
| 09/12/2002 | CA2433850A1 Method for sterilizing bioactive materials |
| 09/12/2002 | CA2432280A1 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 09/12/2002 | CA2431500A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/11/2002 | EP1239042A1 Transposase and method of gene modification |
| 09/11/2002 | EP1239033A1 Semaphorin receptor |
| 09/11/2002 | EP1238982A1 A Fluorescent Protein |
| 09/11/2002 | EP1238584A1 Method for producing livestock individuals from cells of established cell line |
| 09/11/2002 | EP1238281A2 Cancer associated antigens and uses therefor |
| 09/11/2002 | EP1238278A2 Sperm quality assay |
| 09/11/2002 | EP1238095A2 Compositions and methods for caspase-induced apoptosis |
| 09/11/2002 | EP1238092A2 Bovine immunodeficiency virus (biv) based vectors |
| 09/11/2002 | EP1238091A2 Methods and compositions for the manufacture of replication incompetent adenovirus |
| 09/11/2002 | EP1238090A2 Optimized t-dna transfer and vectors therefor |
| 09/11/2002 | EP1238084A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238075A2 Chordin-like molecules and uses thereof |
| 09/11/2002 | EP1238072A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 09/11/2002 | EP1238064A2 Srik a novel cell cycle protein associated with rip3 |
| 09/11/2002 | EP1238063A2 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 09/11/2002 | EP1238062A1 Compositions and methods for halogenation reactions |
| 09/11/2002 | EP1238060A1 Method for production of a skin graft and the graft produced thereby |
| 09/11/2002 | EP1238059A2 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 09/11/2002 | EP1238057A2 Method for producing adherent animal cells |
| 09/11/2002 | EP1238056A2 SEROLOGICAL DIAGNOSTIC METHOD WITH i RICKETTSIA PULICIS /i BACTERIUM |
| 09/11/2002 | EP1237929A1 Dendritic cell-specific antibodies |
| 09/11/2002 | EP1237925A1 MUTANT ER$g(a) AND TEST SYSTEMS FOR TRANSACTIVATION |
| 09/11/2002 | EP1237919A1 Interferon-alpha induced gene |
| 09/11/2002 | EP1237917A2 Protein c derivatives |
| 09/11/2002 | EP1237916A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 09/11/2002 | EP1237915A2 Polynucleotid encoding the rg1 polypeptide |
| 09/11/2002 | EP1237912A2 Five-helix protein |
| 09/11/2002 | EP1237901A1 28 human secreted proteins |
| 09/11/2002 | EP1237900A1 Subunit optimized fusion proteins |
| 09/11/2002 | EP1237582A2 Methods for introducing genes into mammalian subjects |
| 09/11/2002 | EP1237578A2 Micro-cluster liquids and methods of making and using them |
| 09/11/2002 | EP1237565A1 Betaglycan as an inhibin receptor and uses thereof |
| 09/11/2002 | EP1237408A2 Pour-on formulations |
| 09/11/2002 | EP1237405A1 Atp-binding cassette transporter (abc1) modified transgenic mice |
| 09/11/2002 | EP1098991B1 Novel methods for the identification of ligand and target biomolecules |
| 09/11/2002 | EP0954527A4 Glycine transporter-transfected cells and uses thereof |
| 09/11/2002 | EP0944715B1 Pressure-mediated intracellular delivery of molecules or microparticles |
| 09/11/2002 | EP0870053A4 Metabolic engineering of polyhydroxyalkanoate monomer synthases |
| 09/11/2002 | EP0808169A4 Programmed cell death genes and proteins |
| 09/11/2002 | EP0765159B1 Spin encapsulation apparatus and method of use |
| 09/11/2002 | EP0708835B1 Fruit specific promoters |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
| 09/11/2002 | CN1369013A Monocellular or multicellular organisms for production of riboflavin |
| 09/11/2002 | CN1369012A Delta 6-acetylenase and delta-6 desaturase from ceratodon purpureus |
| 09/11/2002 | CN1369010A Compositions affecting programmed cell death and their use in-modification of forestry plant development |
| 09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
| 09/11/2002 | CN1369006A Avian blastodermal cell lines |
| 09/11/2002 | CN1368885A Compositions and methods for identifying antigens which elicit an immune response |
| 09/11/2002 | CN1368842A Biodegradable high oxidative stability oils |
| 09/11/2002 | CN1368551A Process for creating medicine screening system with ABC1 gene cell target to screen 3G medicine of cardiovascular disease |
| 09/11/2002 | CN1090676C Expression systems utilizing autolyzing fusion proteins and novel reducing polypeptide |
| 09/10/2002 | US6448475 Transgenic plants can be made that have altered tocopherol levels in their tissues for increased vitamin e supplementation |
| 09/10/2002 | US6448391 Ubiquitin-lytic peptide fusion gene constructs with enhanced stability and gene expression |
| 09/10/2002 | US6448376 Two new proteins which appear to be new members of the e2f gene family, called e2f-5 |
| 09/10/2002 | US6448375 Active and inactive CC-chemokine receptor |
| 09/10/2002 | US6448230 Testis expressed polypeptide |
| 09/10/2002 | US6448226 Bacillus thuringiensis strains and their insecticidal proteins |
| 09/10/2002 | US6448222 Antitumor agent; antimetastasis agent |
| 09/10/2002 | US6448079 Inhibiting the expression of p38 mitogen activated protein kinase in cells or tissues comprising contacting said cells or tissues in vitro with the antisense compound |
| 09/10/2002 | US6448078 Inhibiting human vpr interacting protein activity in a cell using a nucletide sequence complementary to a portion of the nucleotide sequence that encodes hvip; anticancer agent |
| 09/10/2002 | US6448076 Method for chemically acellularizing a biological tissue sample |
| 09/10/2002 | US6448075 Method for separating cells using immunorosettes |
| 09/10/2002 | US6448074 Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells |
| 09/10/2002 | US6448073 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 09/10/2002 | US6448071 Effective competitors to t cell receptors and mhc molecules normally involved in transplant rejection and autoimmune disease |
| 09/10/2002 | US6448070 Recombinant plant viruses, especially their use as immunizing agents which carry antigenic sequences from mammalian or other animal pathogens and their use as a system for increased production of polypeptides of interest |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | US6448045 Expressing a pdx-1 gene in cells that have been cultured under conditions such that the cells are in contact with other cells in the culture; contacting the cells with a glp-1 receptor agonist, thereby inducing insulin gene expression |
| 09/10/2002 | US6448043 Enterococcus faecalis EF040 and uses therefor |
| 09/10/2002 | US6448042 These enzymes have been implicated in a variety of disease processes, including tumor cell invasion, tumor angiogenesis and rheumatoid arthritis |
| 09/10/2002 | US6448041 Colon cancer marker |
| 09/10/2002 | US6448040 Nucleic acid molecules encoding hypusine mutants having the biological activity, of inhibiting cellular proliferation |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448035 Disorders mediated by disease states associated with suppressed immune function can be treated by administering a soluble form of the negative signaling lir |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6448021 Cc-chemokine receptor 2 (ccr2) bound by an antibody or functional fragment to block binding of a ligand |
| 09/10/2002 | US6448019 Inhibit vascular smooth muscle cell activation and/or proliferation or enhance vascular endothelial cell activation and/or proliferation or activate estrogen responsive genes in vascular cells. vasoprotective agents are vasospecific, |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | US6448007 Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elements |
| 09/10/2002 | US6448005 14723 Receptor, a novel G-protein coupled receptor |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447996 Polypeptides having galanin receptor activity, genetic material for expressing same, any recombinant cell expressing said polypeptides, and the use thereof, are disclosed. |
| 09/10/2002 | US6447993 Protecting cats from infection by a broad range of fiv strains using a multi-subtype fiv vaccine. multi-subtype fiv vaccines comprising either cell free whole virus or cell lines infected with viruses and vaccinating cats |
| 09/10/2002 | US6447813 Plant extracts obtained from living plants |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447776 Monoclonal antibodies against mutant amino acid sequences generated by genetic deletions or point mutations; detection of cancer |
| 09/10/2002 | US6447768 Methods of gene therapy with a DNA sequence encoding NOS |
| 09/10/2002 | US6447765 Use of cytokines and mitogens to inhibit graft versus host disease |
| 09/10/2002 | CA2163218C New macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions |
| 09/10/2002 | CA2073441C Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 09/08/2002 | CA2370324A1 Large circular target-specific antisense nucleic acid compounds |
| 09/06/2002 | WO2002068955A1 Transgenic knockouts of bace-1 |